Small Animals Respiratory Diseases Treatment Market Insights, Global Outlook and Forecast 2022-2028
Small Animals Respiratory Diseases Treatment Market Insights, Global Outlook and Forecast 2022-2028
Analysis of the Small Animals Respiratory Diseases Treatment Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks.
The latest research study released by Market IntelliX evaluates market size and forecasts of Small Animals Respiratory Diseases Treatment in Global, including the following market information:
Global Small Animals Respiratory Diseases Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Small Animals Respiratory Diseases Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anthelmintics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Small Animals Respiratory Diseases Treatment include Zoetis, Inc., Merck Animal Health, Boehringer Ingelheim GmbH, Bayer AG, Ceva Animal Health, Vetoquinol SA and Virbac Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Small Animals Respiratory Diseases Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Small Animals Respiratory Diseases Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Small Animals Respiratory Diseases Treatment Market Segment Percentages, by Type, 2021 (%)
Anthelmintics
Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Antibiotics
Antihistamines
Phosphodiesterase (PDE) inhibitors
Bronchodilators
Antineoplastic Agents
Global Small Animals Respiratory Diseases Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Small Animals Respiratory Diseases Treatment Market Segment Percentages, by Application, 2021 (%)
Allergic Pneumonitis
Canine Influenza
Canine Nasal Mites
Lung Nematodes
Neoplasia Of Respiratory System
Pneumonia
Rhinitis And Sinusitis
Tonsilitis
Global Small Animals Respiratory Diseases Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Small Animals Respiratory Diseases Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Animals Respiratory Diseases Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Small Animals Respiratory Diseases Treatment revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Zoetis, Inc.
Merck Animal Health
Boehringer Ingelheim GmbH
Bayer AG
Ceva Animal Health
Vetoquinol SA
Virbac Ltd.
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Small Animals Respiratory Diseases Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Animals Respiratory Diseases Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Animals Respiratory Diseases Treatment Overall Market Size
2.1 Global Small Animals Respiratory Diseases Treatment Market Size: 2021 VS 2028
2.2 Global Small Animals Respiratory Diseases Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Animals Respiratory Diseases Treatment Players in Global Market
3.2 Top Global Small Animals Respiratory Diseases Treatment Companies Ranked by Revenue
3.3 Global Small Animals Respiratory Diseases Treatment Revenue by Companies
3.4 Top 3 and Top 5 Small Animals Respiratory Diseases Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Small Animals Respiratory Diseases Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Animals Respiratory Diseases Treatment Players in Global Market
3.6.1 List of Global Tier 1 Small Animals Respiratory Diseases Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Animals Respiratory Diseases Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Small Animals Respiratory Diseases Treatment Market Size Markets, 2021 & 2028
4.1.2 Anthelmintics
4.1.3 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
4.1.4 Corticosteroids
4.1.5 Antibiotics
4.1.6 Antihistamines
4.1.7 Phosphodiesterase (PDE) inhibitors
4.1.8 Bronchodilators
4.1.9 Antineoplastic Agents
4.2 By Type - Global Small Animals Respiratory Diseases Treatment Revenue & Forecasts
4.2.1 By Type - Global Small Animals Respiratory Diseases Treatment Revenue, 2017-2022
4.2.2 By Type - Global Small Animals Respiratory Diseases Treatment Revenue, 2023-2028
4.2.3 By Type - Global Small Animals Respiratory Diseases Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Small Animals Respiratory Diseases Treatment Market Size, 2021 & 2028
5.1.2 Allergic Pneumonitis
5.1.3 Canine Influenza
5.1.4 Canine Nasal Mites
5.1.5 Lung Nematodes
5.1.6 Neoplasia Of Respiratory System
5.1.7 Pneumonia
5.1.8 Rhinitis And Sinusitis
5.1.9 Tonsilitis
5.2 By Application - Global Small Animals Respiratory Diseases Treatment Revenue & Forecasts
5.2.1 By Application - Global Small Animals Respiratory Diseases Treatment Revenue, 2017-2022
5.2.2 By Application - Global Small Animals Respiratory Diseases Treatment Revenue, 2023-2028
5.2.3 By Application - Global Small Animals Respiratory Diseases Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Small Animals Respiratory Diseases Treatment Market Size, 2021 & 2028
6.2 By Region - Global Small Animals Respiratory Diseases Treatment Revenue & Forecasts
6.2.1 By Region - Global Small Animals Respiratory Diseases Treatment Revenue, 2017-2022
6.2.2 By Region - Global Small Animals Respiratory Diseases Treatment Revenue, 2023-2028
6.2.3 By Region - Global Small Animals Respiratory Diseases Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Small Animals Respiratory Diseases Treatment Revenue, 2017-2028
6.3.2 US Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.3.3 Canada Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.3.4 Mexico Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Small Animals Respiratory Diseases Treatment Revenue, 2017-2028
6.4.2 Germany Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.4.3 France Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.4.4 U.K. Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.4.5 Italy Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.4.6 Russia Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.4.8 Benelux Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Small Animals Respiratory Diseases Treatment Revenue, 2017-2028
6.5.2 China Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.5.3 Japan Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.5.4 South Korea Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.5.6 India Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Small Animals Respiratory Diseases Treatment Revenue, 2017-2028
6.6.2 Brazil Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.6.3 Argentina Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Small Animals Respiratory Diseases Treatment Revenue, 2017-2028
6.7.2 Turkey Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.7.3 Israel Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
6.7.5 UAE Small Animals Respiratory Diseases Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Zoetis, Inc.
7.1.1 Zoetis, Inc. Corporate Summary
7.1.2 Zoetis, Inc. Business Overview
7.1.3 Zoetis, Inc. Small Animals Respiratory Diseases Treatment Major Product Offerings
7.1.4 Zoetis, Inc. Small Animals Respiratory Diseases Treatment Revenue in Global Market (2017-2022)
7.1.5 Zoetis, Inc. Key News
7.2 Merck Animal Health
7.2.1 Merck Animal Health Corporate Summary
7.2.2 Merck Animal Health Business Overview
7.2.3 Merck Animal Health Small Animals Respiratory Diseases Treatment Major Product Offerings
7.2.4 Merck Animal Health Small Animals Respiratory Diseases Treatment Revenue in Global Market (2017-2022)
7.2.5 Merck Animal Health Key News
7.3 Boehringer Ingelheim GmbH
7.3.1 Boehringer Ingelheim GmbH Corporate Summary
7.3.2 Boehringer Ingelheim GmbH Business Overview
7.3.3 Boehringer Ingelheim GmbH Small Animals Respiratory Diseases Treatment Major Product Offerings
7.3.4 Boehringer Ingelheim GmbH Small Animals Respiratory Diseases Treatment Revenue in Global Market (2017-2022)
7.3.5 Boehringer Ingelheim GmbH Key News
7.4 Bayer AG
7.4.1 Bayer AG Corporate Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Small Animals Respiratory Diseases Treatment Major Product Offerings
7.4.4 Bayer AG Small Animals Respiratory Diseases Treatment Revenue in Global Market (2017-2022)
7.4.5 Bayer AG Key News
7.5 Ceva Animal Health
7.5.1 Ceva Animal Health Corporate Summary
7.5.2 Ceva Animal Health Business Overview
7.5.3 Ceva Animal Health Small Animals Respiratory Diseases Treatment Major Product Offerings
7.5.4 Ceva Animal Health Small Animals Respiratory Diseases Treatment Revenue in Global Market (2017-2022)
7.5.5 Ceva Animal Health Key News
7.6 Vetoquinol SA
7.6.1 Vetoquinol SA Corporate Summary
7.6.2 Vetoquinol SA Business Overview
7.6.3 Vetoquinol SA Small Animals Respiratory Diseases Treatment Major Product Offerings
7.6.4 Vetoquinol SA Small Animals Respiratory Diseases Treatment Revenue in Global Market (2017-2022)
7.6.5 Vetoquinol SA Key News
7.7 Virbac Ltd.
7.7.1 Virbac Ltd. Corporate Summary
7.7.2 Virbac Ltd. Business Overview
7.7.3 Virbac Ltd. Small Animals Respiratory Diseases Treatment Major Product Offerings
7.7.4 Virbac Ltd. Small Animals Respiratory Diseases Treatment Revenue in Global Market (2017-2022)
7.7.5 Virbac Ltd. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Small Animals Respiratory Diseases Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|